Nancy Huynh Participating in Pfizer Organic Chemistry Symposium
Graduate student Nancy Huynh of the Krische Group has been invited to participate in the Pfizer Organic Chemistry Symposium on Tuesday, November 10th. Nancy's research talk is titled, "Enantioselective Ruthenium-Catalyzed Benzocyclobutenone-Ketol Cycloaddition & Progress Towards the Total Synthesis of Arenimycin A" and is summarized below. The goal of this symposium is to champion diversity and inclusion.
Enantioselective Ruthenium-Catalyzed Benzocyclobutenone-Ketol Cycloaddition & Progress Towards the Total Synthesis of Arenimycin A
The emergence of antibiotic resistance is becoming a persistent problem. Still, antibiotics remain the gold standard of treatment for bacterial infections where constant search for novel chemical molecules remains a priority. The Krische group is utilizing methods of transfer-hydrogenative ruthenium-catalyzed transformations to access key motifs of type II polyketide natural products.
